The TLR4/MYD88/STAT3 and TLR4/TRIF/STAT3 pathways established in this study shed novel insights into the pathophysiology of melanoma, and suggest new, potentially more effective, targets for treating melanoma. This evidence concerns the gene TLR4 and melanoma.